| 发明名称 |
Use of active pharmaceutical compounds for the treatment of central nervous system conditions |
| 摘要 |
<p>The present invention relates to the pharmaceutical use of selective GABA Aα5 negative allosteric modulators for the treatment, prevention and/or delay of progression of central nervous system (CNS) conditions related to excessive GABAergic inhibition in the brain.</p> |
| 申请公布号 |
AU2011325190(B2) |
申请公布日期 |
2015.05.14 |
| 申请号 |
AU20110325190 |
申请日期 |
2011.11.01 |
| 申请人 |
F. HOFFMANN-LA ROCHE AG |
发明人 |
GASSER, RODOLFO;HERNANDEZ, MARIA-CLEMENCIA;THOMAS, ANDREW |
| 分类号 |
A61K31/4439;A61K31/551;A61P25/28 |
主分类号 |
A61K31/4439 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
